Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DACARBAZINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 251 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Safgren, SL; Reid, JM; Rios, R; Ames, MM
      Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide

      JOURNAL OF CHROMATOGRAPHY B
    2. Camci, C; Sari, R; Sevinc, A; Buyukberber, S
      Dacarbazine-induced carotid artery and deep venous thrombosis in a patientwith leiomyosarcoma: Case report

      JOURNAL OF CHEMOTHERAPY
    3. Spiro, TP; Liu, L; Majka, S; Haaga, J; Willson, JKV; Gerson, SL
      Temozolomide: The effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O-6-alkylguanine-DNA-alkyltransferase

      CLINICAL CANCER RESEARCH
    4. Huang, YC; Hsu, KF; Chou, CY; Dai, YC; Tzeng, CC
      Ovarian fibrosarcoma with long-term survival: A case report

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    5. Dummer, R; Bosch, U; Panizzon, R; Bloch, PH; Burg, G
      Swiss guidelines for the treatment and follow-up of cutaneous melanoma

      DERMATOLOGY
    6. Wack, C; Becker, JC; Brocker, EB; Lutz, WK; Fischer, WH
      Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model

      MELANOMA RESEARCH
    7. Mc Clay, EF; Mc Clay, MET; Monroe, L; Jones, JA; Winski, PJ
      A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

      MELANOMA RESEARCH
    8. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    9. Huncharek, M; Caubet, JF; McGarry, R
      Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

      MELANOMA RESEARCH
    10. Eggermont, AMM
      The role interferon-alpha in malignant melanoma remains to be defined

      EUROPEAN JOURNAL OF CANCER
    11. Hartley, A; Spooner, D; Brunt, AM
      Management of malignant phaeochromocytoma: A retrospective review of the use of MIBG and chemotherapy in the West Midlands

      CLINICAL ONCOLOGY
    12. Moretti, S; Carli, P; Biggeri, A; Volpi, V; Pimpinelli, N
      Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    13. Ramanathan, RK; Cnaan, A; Hahn, RG; Carbone, PP; Haller, DG
      Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

      ANNALS OF ONCOLOGY
    14. Ferrari, A; Bisogno, G; Casanova, M; Meazza, C; Cecchetto, G; Mancini, MA; Zanetti, I; Alaggio, R; Ninfo, V; Carli, M
      Childhood leiomyosarcoma: A report from theSoft Tissue Sarcoma Italian Cooperative Group

      ANNALS OF ONCOLOGY
    15. Bangalore, N; Bhargava, P; Hawkins, MJ; Bhargava, P
      Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature

      ANNALS OF ONCOLOGY
    16. Flaherty, LE; Atkins, M; Sosman, J; Weiss, G; Clark, JI; Margolin, K; Dutcher, J; Gordon, MS; Lotze, M; Mier, J; Sorokin, P; Fisher, RI; Appel, C; Du, W
      Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II cytokineworking group trials

      JOURNAL OF CLINICAL ONCOLOGY
    17. Kim, H; Likhari, P; Parker, D; Statkevich, P; Marco, A; Lin, CC; Nomeir, AA
      High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    18. Liu, JD; Chen, SH; Lin, CL; Tsai, SH; Liang, YC
      Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice

      JOURNAL OF CELLULAR BIOCHEMISTRY
    19. Zheleva, AM; Gadjeva, VG
      Spin labelled nitrosoureas and triazenes and their non-labelled clinicallyused analogues - a comparative study on their physicochemical properties and antimelanomic effects

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    20. Tentori, L; Portarena, I; Vernole, P; De Fabritiis, P; Madaio, R; Balduzzi, A; Roy, R; Bonmassar, E; Graziani, G
      Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Frustaci, S; Buonadonna, A; La Mura, N; Libra, M
      Chemotherapy

      TUMORI
    22. Kaltsas, G; Mukherjee, JJ; Plowman, PN; Grossman, AB
      The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours

      CLINICAL ENDOCRINOLOGY
    23. Otsuka, K; Hamakawa, H; Sumida, T; Tanioka, H
      Treatment of mandibular malignant fibrous histiocytoma during pregnancy

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    24. Nieboer, P; Mulder, NH; Van Der Graaf, WTA; Willemse, PHB; Hospers, GAP
      Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma

      ANTICANCER RESEARCH
    25. Margolin, K; Longmate, J; Synold, TW; Gandara, DR; Weber, J; Gonzalez, R; Johansen, MJ; Newman, R; Baratta, T; Doroshow, JH
      Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium

      INVESTIGATIONAL NEW DRUGS
    26. Boiardi, A; Silvani, A; Ciusani, E; Watson, A; Margison, G; Berger, E; Lucas, C; Giroux, B
      Fotemustine combined with procarbazine in recurrent malignant gliomas: A phase I study with evaluation of lymphocyte O-6-alkylguanine-DNA alkyltransferase activity

      JOURNAL OF NEURO-ONCOLOGY
    27. Klingler, HC; Klingler, PJ; Martin, JK; Smallridge, RC; Smith, SL; Hinder, RA
      Pheochromocytoma

      UROLOGY
    28. Joukhadar, C; Klein, N; Mader, RM; Schrolnberger, C; Rizovski, B; Heere-Ress, E; Pehamberger, H; Strauchmann, N; Jansen, B; Muller, M
      Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma

      CANCER
    29. O'Day, SJ; Boasberg, PD; Kristedja, TS; Martin, M; Wang, HJ; Fournier, P; Cabot, M; DeGregorio, MW; Gammon, G
      High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma

      CANCER
    30. Ansell, SM; Pitot, HC; Burch, PA; Kvols, LK; Mahoney, MR; Rubin, J
      A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

      CANCER
    31. Unger, JM; Flaherty, LE; Liu, PY; Albain, KS; Sondak, VK
      Gender and other survival predictors in patients with metastatic melanoma on southwest oncology group trials

      CANCER
    32. Dillman, RO; Soori, G; Wiemann, MC; Schulof, R; Dobbs, TW; Ruben, RH; DePriest, CB; Church, C
      Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    33. Atkins, MB
      Interleukin-2 in metastatic melanoma: What is the current role?

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    34. Flaherty, LE
      Rationale for intergroup trial E-3695 comparing concurrent biochemotherapyth cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    35. Schwenka, J; Ignoffo, RJ
      Temozolomide - A new option for high-grade astrocytomas

      CANCER PRACTICE
    36. Ciaravino, G; Kapp, DS; Vela, AM; Fulton, RS; Lum, BL; Teng, NNH; Roberts, JA
      Primary leiomyosarcoma of the vagina. A case report and literature review

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    37. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    38. Kubo, H; Matsumoto, K; Funahashi, M; Takagi, H; Kitajima, Y; Taniguchi, S; Saida, T
      Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice

      MELANOMA RESEARCH
    39. Gibbs, P; Iannucci, A; Becker, M; Allen, J; O'Driscoll, M; McDowell, K; Williams, P; Rosse, P; Murphy, J; Gonzalez, R
      A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma

      MELANOMA RESEARCH
    40. Lee, ML; Tomsu, K; Von Eschen, KB
      Duration of survival for disseminated malignant melanoma: results of a meta-analysis

      MELANOMA RESEARCH
    41. Schrader, AJ
      Combined chemoimmunotherapy in metastatic melanoma - is there a need for the double?

      ANTI-CANCER DRUGS
    42. Hwu, WJ
      New approaches in the treatment of metastatic melanoma: Thalidomide and temozolomide

      ONCOLOGY-NEW YORK
    43. Foon, KA; Lutzky, J; Baral, RN; Yannelli, JR; Hutchins, L; Teitelbaum, A; Kashala, OL; Das, R; Garrison, J; Reisfeld, RA; Bhattacharya-Chatterjee, M
      Clinical and immune responses in advanced melanoma patients immunized withan anti-idiotype antibody mimicking disialoganglioside GD2

      JOURNAL OF CLINICAL ONCOLOGY
    44. Jen, JF; Cutler, DL; Pai, SM; Batra, VK; Affrime, MB; Zambas, DN; Heft, S; Hajian, G
      Population pharmacokinetics of temozolomide in cancer patients

      PHARMACEUTICAL RESEARCH
    45. Kruijtzer, CMF; Beijnen, JH; Swart, M; Schellens, JHM
      Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma) - A case report and review of the literature

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    46. Braybrooke, JP; Houlbrook, S; Crawley, JE; Propper, DJ; O'Byrne, KJ; Stratford, IJ; Harris, AL; Shuker, DEG; Talbot, DC
      Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    47. Middleton, MR; Kelly, J; Goodger, S; Thatcher, N; Margison, GP
      Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    48. Becker, JC; Kampgen, E; Brocker, EB
      Classical chemotherapy for metastatic melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    49. Baekke, J; Rytter, C; Mouridsen, H; Madsen, EL; Moholt, K; Bastholt, L
      A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma

      ACTA ONCOLOGICA
    50. Perissin, L; Facchin, P; Bedini, A; Diamantini, G; Tontini, A; Tarzia, G
      Antimetastatic action of a new analog of dacarbazine in mice bearing Lewislung carcinoma

      ANTICANCER RESEARCH
    51. Rajkumar, SV; Reid, JM; Novotny, PJ; Safgren, SL; Scheithauer, BW; Johnson, PS; Nair, S; Morton, RF; Hatfield, AK; Krook, JE; Ames, MM; Buckner, JC
      A randomized phase II and pharmacokinetic study of dacarbazine in patientswith recurrent glioma

      JOURNAL OF NEURO-ONCOLOGY
    52. Jansen, B; Wacheck, V; Heere-Ress, E; Schlagbauer-Wadl, H; Hoeller, C; Lucas, T; Hoermann, M; Hollenstein, U; Wolff, K; Pehamberger, H
      Chemosensitisation of malignant melanoma by BCL2 antisense therapy

      LANCET
    53. Mota, A; Deisseroth, A
      Systemic treatment of malignant melanoma

      CLINICS IN PLASTIC SURGERY
    54. Sutton, G; Brunetto, VL; Kilgore, L; Soper, JT; McGehee, R; Olt, G; Lentz, SS; Sorosky, J; Hsiu, JG
      A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A gynecologic oncology group study

      GYNECOLOGIC ONCOLOGY
    55. Middleton, MR; Lee, SM; Arance, A; Wood, M; Thatcher, N; Margison, GP
      O-6-methylguanine formation, repair protein depletion and clinical outcomewith a 4 hr schedule of temozolomide in the treatment of advanced melanoma: Results of phase II study

      INTERNATIONAL JOURNAL OF CANCER
    56. Daponte, A; Ascierto, PA; Gravina, A; Melucci, MT; Palmieri, G; Comella, P; Cellerino, R; DeLena, M; Marini, G; Comella, G
      Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

      CANCER
    57. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    58. Feun, LG; Savaraj, M; Hurley, J; Marini, A; Lai, SH
      A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in thetreatment of patients with advanced malignant melanoma

      CANCER
    59. Aglietta, M; Montemurro, F; Fagioli, F; Volta, C; Botto, B; Cantonetti, M; Racanelli, V; Teofili, L; Ferrara, R; Amadori, S; Castoldi, GL; Dammacco, F; Levis, A
      Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease

      CANCER
    60. Keilholz, U; Suciu, S; Eggermont, AMM
      What can we learn from phase II adjuvant trials in melanoma?

      BRITISH JOURNAL OF CANCER
    61. McClay, EF; McClay, MET; Monroe, L; Baron, PL; Cole, DJ; O'Brien, PH; Metcalf, JS; Maize, JC
      The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma

      BRITISH JOURNAL OF CANCER
    62. DeMatteo, RP; Lewis, JJ; Leung, D; Mudan, SS; Woodruff, JM; Brennan, MF
      Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival

      ANNALS OF SURGERY
    63. Dummer, R; Nestle, FO; Burg, G
      Immune therapy of melanoma

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    64. Pappo, AS; Parham, DM; Rao, BN; Lobe, TE
      Soft tissue sarcomas in children

      SEMINARS IN SURGICAL ONCOLOGY
    65. Hernberg, M; Pyrhonen, S; Muhonen, T
      Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials

      JOURNAL OF IMMUNOTHERAPY
    66. Naglieri, E; Procacci, A; Galetta, D; Abbate, I; Dell'Erba, L; Colucci, G
      Cisplatin, interleukin-2, interferon-alpha and tamoxifen in metastatic melanoma. A phase II study

      JOURNAL OF CHEMOTHERAPY
    67. Sampson, JH; Archer, GE; Villavicencio, AT; McLendon, RE; Friedman, AH; Bishop, WR; Bigner, DD; Friedman, HS
      Treatment of neoplastic meningitis with intrathecal temozolomide

      CLINICAL CANCER RESEARCH
    68. Baker, SD; Wirth, M; Statkevich, P; Reidenberg, P; Alton, K; Sartorius, SE; Dugan, M; Cutler, D; Batra, V; Grochow, LB; Donehower, RC; Rowinsky, EK
      Absorption, metabolism, and excretion of C-14-temozolomide following oral administration to patients with advanced cancer

      CLINICAL CANCER RESEARCH
    69. Neuber, K; Dieck, AT; Blodorn-Schlicht, N; Itschert, G; Karnbach, C
      Treosulfan is an effective alkylating cytostatic for malignant melanoma invitro and in vivo

      MELANOMA RESEARCH
    70. Samuels, BL
      Management of recurrent desmoid tumor after surgery and radiation: role ofcytotoxic and non-cytotoxic therapies

      SURGICAL ONCOLOGY-OXFORD
    71. Takahashi, K; Ashizawa, N; Minami, T; Suzuki, S; Sakamoto, I; Hayashi, K; Tomiyasu, S; Sumikawa, K; Kitamura, K; Eto, T; Yano, K
      Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization

      INTERNAL MEDICINE
    72. Isozaki, T; Kiba, T; Numata, K; Saito, S; Shimamura, T; Kitamura, T; Morita, K; Tanaka, K; Sekihara, H
      Medullary thyroid carcinoma with multiple hepatic metastases: Treatment with transcatheter arterial embolization and percutaneous ethanol injection

      INTERNAL MEDICINE
    73. O'Day, SJ; Gammon, G; Boasberg, PD; Martin, MA; Kristedja, TS; Guo, M; Stern, S; Edwards, S; Fournier, P; Weisberg, M; Cannon, M; Fawzy, NW; Johnson, TD; Essner, R; Foshag, LJ; Morton, DL
      Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    74. Atkins, MB; Lotze, MT; Dutcher, JP; Fisher, RI; Weiss, G; Margolin, K; Abrams, J; Sznol, M; Parkinson, D; Hawkins, M; Paradise, C; Kunkel, L; Rosenberg, SA
      High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993

      JOURNAL OF CLINICAL ONCOLOGY
    75. Richards, JM; Gale, D; Mehta, N; Lestingi, T
      Combination of chemotherapy with interleukin-2 and interferon alfa for thetreatment of metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    76. Pletsa, V; Steenwinkel, MJST; van Delft, JHM; Baan, RA; Kyrtopoulos, SA
      Methyl bromide causes DNA methylation in rats and mice but fails to inducesomatic mutations in lambda lacZ transgenic mice

      CANCER LETTERS
    77. Frustaci, S; Buonadonna, A; Romanini, A; Comandone, A; Dalla Palma, M; Gamucci, T; Verusio, C; Lionetto, R; Dani, C; Casali, P; Santoro, A
      Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors

      TUMORI
    78. Sisson, JC; Shapiro, B; Shulkin, BL; Urba, S; Zempel, S; Spaulding, S
      Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    79. Mahmood, T; Mudad, R
      Carcinoid syndrome with unknown primary - A case report

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    80. Chevreau, C; Bui, BN; Chevallier, B; Krakowski, I; Maugard, C; Mihura, J; Coindre, JM; Gil, B; Cour-Chabernaud, V
      Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    81. Diana, P; Barraja, P; Lauria, A; Almerico, AM; Cirrincione, G; Loi, AG; Musiu, C; Pani, A; La Colla, P; Marongiu, ME
      2-triazenopyrroles: synthesis and biological activity

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    82. Pappo, AS; Rao, BN; Jenkins, JJ; Merchant, T; Poquette, CA; Cain, A; Pratt, CB
      Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience

      MEDICAL AND PEDIATRIC ONCOLOGY
    83. Platt, JS; Rogers, SJ; Flynn, EA; Taylor, RR
      Primary angiosarcoma of the ovary: A case report and review of the literature

      GYNECOLOGIC ONCOLOGY
    84. Icli, F; Arican, A; Cay, F; Akbulut, H; Dincol, D; Karaoguz, H; Demirkazik, A
      Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil

      ONCOLOGY
    85. Ollila, DW; Hsueh, EC; Stern, SL; Morton, DL
      Metastasectomy for recurrent stage IV melanoma

      JOURNAL OF SURGICAL ONCOLOGY
    86. Kashani-Sabet, M; Sagebiel, RW; Collins, HE; Glassberg, AB; Allen, RE; Leong, SPL; Small, EJ
      Outpatient combination chemoimmunotherapy for patients with metastatic melanoma - Results of a phase I/II trial

      CANCER
    87. Mirossay, A; Mojzis, J; Sulla, I; Vyrostko, J; Sokol, L; Mirossay, L
      A first experience with in vitro testing of the sensitivity of brain tumorcells to chemotherapeutic drugs

      BIOLOGIA
    88. AGARWALA SS; KIRKWOOD JM
      ADJUVANT THERAPY OF MELANOMA

      Seminars in surgical oncology
    89. NATHAN FE; MASTRANGELO MJ
      SYSTEMIC THERAPY IN MELANOMA

      Seminars in surgical oncology
    90. DIVAGNO G; CORMIO G; LOVERRO G; MELILLI GA; DIGESU G; SELVAGGI L
      PROLONGED SURVIVAL OF STAGE-IV MALIGNANT MIXED MULLERIAN TUMOR OF THEOVARY AFTER CARBOPLATIN, MESNA, IFOSFAMIDE, AND CISPLATIN CHEMOTHERAPY - CASE-REPORT

      Journal of chemotherapy
    91. SCHACHTER J; RAKOWSKY E; SULKES A; ADLER A
      A SEQUENTIAL 4-DRUG CHEMOTHERAPY AND BIOTHERAPY WITH INTERFERON-ALPHAAND GM-CSF - AN INNOVATIVE PROTOCOL FOR THE TREATMENT OF METASTATIC MELANOMA

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    92. PUNT CJA
      THE USE OF INTERFERON-ALPHA IN THE TREATMENT OF CUTANEOUS MELANOMA - A REVIEW

      Melanoma research
    93. RICHARD MA; GROB JJ; ZARROUR H; BASSERES N; BIZZARI JP; GERARD B; BONERANDI JJ
      COMBINED TREATMENT WITH DACARBAZINE, CISPLATIN, FOTEMUSTINE AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA

      Melanoma research
    94. Buzaid, AC; Colome, M; Bedikian, A; Eton, O; Legha, SS; Papadopoulos, N; Plager, C; Ross, M; Lee, JE; Mansfield, P; Rice, J; Ring, S; Lee, JJ; Strom, E; Benjamin, R
      Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

      MELANOMA RESEARCH
    95. Semb, KA; Aamdal, S; Bohmann, T; Lucas, C; Gerard, B
      Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma

      MELANOMA RESEARCH
    96. FELESZKO W; ZAGOZDZON R; GOLAB J; JAKOBISIAK M
      POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE

      European journal of cancer
    97. RUSTHOVEN JJ
      THE EVIDENCE FOR TAMOXIFEN AND CHEMOTHERAPY AS TREATMENT FOR METASTATIC MELANOMA

      European journal of cancer
    98. Seeber, A; Binder, M; Steiner, A; Wolff, K; Pehamberger, H
      Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

      EUROPEAN JOURNAL OF CANCER
    99. GREEN RJ; SCHUCHTER LM
      SYSTEMIC TREATMENT OF METASTATIC MELANOMA WITH CHEMOTHERAPY

      Hematology/oncology clinics of North America
    100. GAUSE BL; SHARFMAN WH; JANIK JE; CURTI BD; STEIS RG; URBA WJ; SMITH JW; ALVORD WG; LONGO SL
      A PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, INTERFERON-ALPHA, AND TAMOXIFEN FOR PATIENTS WITH METASTATIC MELANOMA

      Cancer investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:19:21